Cash & equivalents increased 438.9%
Cash & equivalents changed +438.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +438.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Premiums earned changed +112.1% from the comparable as-filed period.
Policy benefits and claims changed +1511.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
Revenue changed +80.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Net income changed -18.3% from the comparable as-filed period.
Total assets changed +11.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Stockholders' equity changed +7.0% from the comparable as-filed period.
Shares outstanding changed -2.3% from the comparable as-filed period. The change ranks at the 12th percentile of 8 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.